B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 29.45 SEK 1.38% Market Closed
Market Cap: 1.9B SEK

During the last 3 months BioInvent International AB insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 29% over this period (open performance analysis).

The last transaction was made on Feb 23, 2024 by Erik Esveld (Vice President of Clinical Development) , who bought 84.6k SEK worth of BINV shares.

Last Transactions:
Erik Esveld
Vice President of Clinical Development
kr+84.6k
Erik Esveld
Vice President of Clinical Development
kr+71k
Erik Esveld
Vice President of Clinical Development
kr+156.4k
Bernd Seizinger
Chairman of the Board
kr+141.1k
Bernd Seizinger
Chairman of the Board
kr+169.4k
Bernd Seizinger
Chairman of the Board
kr+67.8k
Bernd Seizinger
Chairman of the Board
kr+61.8k
Bernd Seizinger
Chairman of the Board
kr+163.2k
Kristoffer Bissessar
Chief Financial Officer
kr+238k
Sylvie Ryckebusch
Chief Business Officer
kr+7.9k
Dharminder Chahal
Board Member
kr+352.5k
Martin Welschof
CEO
kr+612.4
Martin Welschof
CEO
kr+17.2k
Martin Welschof
CEO
kr+16.8k
Martin Welschof
CEO
kr+109.8k
Martin Welschof
CEO
kr+6.7k
Martin Welschof
CEO
kr+20.7k
Martin Welschof
CEO
kr+25.4k
Martin Welschof
CEO
kr+27.2k
Martin Welschof
CEO
kr+11.2k
Martin Welschof
CEO
kr+13.7k
Bernd Seizinger
Chairman of the Board
kr+13.4k
Bernd Seizinger
Chairman of the Board
kr+100.8k
Bernd Seizinger
Chairman of the Board
kr+72.8k
Bernd Seizinger
Chairman of the Board
kr+12.5k
Bernd Seizinger
Chairman of the Board
kr+7.4k
Bernd Seizinger
Chairman of the Board
kr+119.7
Bernd Seizinger
Chairman of the Board
kr+20.4k
Bernd Seizinger
Chairman of the Board
kr+30.2k
Bernd Seizinger
Chairman of the Board
kr+600
Bernd Seizinger
Chairman of the Board
kr+20k
Bernd Seizinger
Chairman of the Board
kr+120.7k
View All Transactions

During the last 3 months BioInvent International AB insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 29% over this period (open performance analysis).

The last transaction was made on Feb 23, 2024 by Erik Esveld (Vice President of Clinical Development) , who bought 84.6k SEK worth of BINV shares.

Sold
0-3
months
0 SEK
0
3-6
months
0 SEK
0
6-9
months
0 SEK
0
9-12
months
0 SEK
0
Bought
0-3
months
No Insider Transactions
0
0 SEK
3-6
months
No Insider Transactions
0
0 SEK
6-9
months
No Insider Transactions
0
0 SEK
9-12
months
No Insider Transactions
0
0 SEK

BioInvent International AB
Insider Trading Chart

BioInvent International AB
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

BioInvent International AB
Last Insider Transactions

Global
Insiders Monitor

BioInvent International AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

BINV Intrinsic Value
84 SEK
Undervaluation 65%
Intrinsic Value
Price
B

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top